Atıf Formatları
Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

H. (Editor) Çiftçi Et Al. Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders. Lausanne: Frontiers Media SA2024, pp.123

Çiftçi, H. (Editor) Et Al. 2024. Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders . Frontiers Media SA, Lausanne.

Çiftçi, H. (Editor), Sever, B. (Editor), Saso, L. (Editor), Tzoneva, R. (Editor), & Onnis, V. (Editor), (2024). Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders . Lausanne: Frontiers Media SA.

Çiftçi, Halilibrahim Et Al. Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders . Lausanne: Frontiers Media SA, 2024

Çiftçi, Halilibrahim Et Al. Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders . Frontiers Media SA, 2024.

Çiftçi, H. (Editor) Et Al. (2024) Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders . 1st edn. Lausanne: Frontiers Media SA.

@book{book, author={Halilibrahim Çiftçi Et Al. }, title={Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders}, publisher={Frontiers Media SA}, year={2024} }